Content
Frontiers of Medicine >> 2020, Volume 14, Issue 2 doi: 10.1007/s11684-020-0750-4
Development of oncolytic virotherapy: from genetic modification to combination therapy
. Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, China.. Yantai Yuhuangding Hospital, Qingdao University, Yantai 264000, China.. Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA
Abstract
Keywords
immunotherapy ; oncolytic virus ; genetic modification ; immune checkpoint blockade ; chimeric antigen receptor T cell
Content